Marksans Pharma - Plagued by FDA issues, price have reached bottom in the past years. Hailed as next Glenmark once. Now showing momentum as overall sector is bullish. Good Promoter Holdings and increased FII/FPI participation seen. Can look for long term investment with a stop@ aggressive 50 or 45.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.